For example, the role of GPER in ERα+ breast cancer cells that are “addicted” to ER-mediated signaling/gene expression for growth, and thus sensitive to antiestrogen/hormone therapy, may be very different compared to ER−/triple negative cells. This evidence concerns the gene ESR1 and breast cancer.